博九娱乐网

Assembly Biosciences, Inc., a biopharmaceutical company, develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus (HBV) and C. difficile-associated infections (CDAD). It is involved in developing core protein allosteric modulators that modulate the HBV core protein, a polyfunctional viral protein, at various complementary…More points in the viral lifecycle; and microbiome program, a treatment for CDAD, for targeted delivery of complex agents to select regions of the gastrointestinal tract.